CEO Jan Mikkelsen highlighted 2024 as a pivotal year, with SKYTROFA achieving €200 million in revenue and a 6.5% share of the U.S. growth hormone market. The product now holds 45% of the U.S.

TD Cowen analysts made adjustments to the stock of Fidelity National Information Services (NYSE:FIS), reducing the price target to $81 from the previous $87 while maintaining a Hold rating on the ...

TD Cowen has upgraded CRISPR Therapeutics (CRSP) to hold from sell, stating it now sees less downside to the stock. Read more ...

TD Cowen analyst William Katz maintained a Hold rating on Artisan Partners (APAM – Research Report) today and set a price target of $46.00. The ...

TD Cowen analyst William Katz maintained a Hold rating on Carlyle Group (CG – Research Report) today and set a price target of $54.00. The ...

On Tuesday, during a House Financial Services Committee hearing, U.S. lawmakers exhibited a divide in their approaches to regulating cryptocurrencies and stablecoins, highlighting the challenges in ...

Mr. Hutchison’s change came in the wake of Tuesday’s premarket release of fourth-quarter 2024 operating results and updated ...

Teledyne Technologies Incorporated (NYSE:TDY) today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will present at the TD Cowen 46th Annual ...

TD Cowen reiterated its Buy rating on Apollo Global Management (NYSE:APO) shares, maintaining a price target of $214.00.

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using its ...